Ahmed R. Rabea
Cairo, C 11976, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Programmed cell death protein 1 (PD-1) / programmed cell death ligand 1 (PD-L1) in multiple myeloma.
Programmed cell death protein 1 (PD-1) / programmed cell death ligand 1 (PD-L1) in multiple myeloma.
Journal: Journal of the Egyptian National Cancer Institute
Published: May 24, 2025
Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients With Relapsed/Refractory Multiple Myeloma: Recommendations From the Middle East and North Africa Expert Panel.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 23, 2025
Modified bentonite @ microwave for Mn(VII) removal with a simulation study.
Journal: Scientific reports
Published: November 04, 2024
Prevalence of RUNX1 gene alterations in de novo adult acute myeloid leukemia.
Journal: World journal of experimental medicine
Published: July 24, 2024
Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study.
Journal: International journal of immunopathology and pharmacology
Published: January 17, 2023
Overexpression of cancerous inhibitor ofPP2A (CIP2A) in acute myeloid leukemia.
Journal: Expert review of hematology
Published: May 03, 2022
Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients.
Journal: Journal, genetic engineering & biotechnology
Published: February 10, 2021
Batwing mammoplasty: a safe oncoplastic technique for breast conservation in breast cancer patients with gigantomastia.
Journal: Annals of the Royal College of Surgeons of England
Published: September 21, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026